Macmillan Cancer Pathways Programme Evaluation

Macmillan Cancer Support has commissioned MEL Research to carry out an evaluation of the Macmillan Cancer Pathways Programme, which has been delivered at Nottingham University Hospitals NHS Trust (NUH) since 2014.


 

The programme aims to improve patient outcomes and experience by redesigning cancer care follow-up pathways at NUH. The programme began in March 2014 and contributes to the delivery of the living with cancer recommendations set out in the current national policy for cancer services, Achieving World Class Outcomes: A Strategy for Cancer 2015-2020.


Specifically, the programme is working with key stakeholders across primary, secondary and tertiary care sectors to develop integrated stratified follow up (SFU) pathways for patients diagnosed with cancer. The programme aims include avoiding duplication, developing consistent pathways across the region, and to agree with all stakeholders and implement pathways that are based on the total needs of the patient from diagnosis.


The programme constitutes a collaboration between the Hospital, Macmillan Cancer Support, the six local Clinical Commissioning Groups, voluntary services, and Public Health, and sits at the heart of the Macmillan Cancer Partnership in Nottinghamshire.


This important evaluation will review and evaluate Cancer Pathways Programme activity and learning to-date, with the findings providing an evidence base which will inform decisions about role commissioning and resources for potential roll-out of the programme beyond March 2020.


If you would like to read more about our other projects please click here, or contact the team today on 0121 604 4664 if you have a project in mind that you wish to discuss

MRS Evidence Matters